| pubmed-article:20585130 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20585130 | lifeskim:mentions | umls-concept:C0003232 | lld:lifeskim |
| pubmed-article:20585130 | lifeskim:mentions | umls-concept:C0018483 | lld:lifeskim |
| pubmed-article:20585130 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:20585130 | lifeskim:mentions | umls-concept:C0006968 | lld:lifeskim |
| pubmed-article:20585130 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:20585130 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
| pubmed-article:20585130 | lifeskim:mentions | umls-concept:C1568612 | lld:lifeskim |
| pubmed-article:20585130 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:20585130 | pubmed:dateCreated | 2010-8-18 | lld:pubmed |
| pubmed-article:20585130 | pubmed:abstractText | In vitro activity of tebipenem, a new oral carbapenem antibiotic, against clinical Haemophilus influenzae isolates was compared with those of 8 reference agents. Isolates were classified into 6 resistance classes after PCR identification of beta-lactamase genes and ftsI gene mutations. For all isolates, the minimal concentration at which 90% of isolates were inhibited was lower for tebipenem than for the reference oral antibiotics, except for cefditoren. Tebipenem also showed excellent bactericidal activity against beta-lactamase-nonproducing, ampicillin-resistant isolates. | lld:pubmed |
| pubmed-article:20585130 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20585130 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20585130 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20585130 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20585130 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20585130 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20585130 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20585130 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20585130 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20585130 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20585130 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20585130 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20585130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20585130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20585130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20585130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20585130 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20585130 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:20585130 | pubmed:issn | 1098-6596 | lld:pubmed |
| pubmed-article:20585130 | pubmed:author | pubmed-author:UbukataKimiko... | lld:pubmed |
| pubmed-article:20585130 | pubmed:author | pubmed-author:ChibaNaokoN | lld:pubmed |
| pubmed-article:20585130 | pubmed:author | pubmed-author:IdaTakashiT | lld:pubmed |
| pubmed-article:20585130 | pubmed:author | pubmed-author:OnoAkikoA | lld:pubmed |
| pubmed-article:20585130 | pubmed:author | pubmed-author:MorozumiMiyuk... | lld:pubmed |
| pubmed-article:20585130 | pubmed:author | pubmed-author:KishiiKozueK | lld:pubmed |
| pubmed-article:20585130 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20585130 | pubmed:volume | 54 | lld:pubmed |
| pubmed-article:20585130 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20585130 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20585130 | pubmed:pagination | 3970-3 | lld:pubmed |
| pubmed-article:20585130 | pubmed:dateRevised | 2011-7-25 | lld:pubmed |
| pubmed-article:20585130 | pubmed:meshHeading | pubmed-meshheading:20585130... | lld:pubmed |
| pubmed-article:20585130 | pubmed:meshHeading | pubmed-meshheading:20585130... | lld:pubmed |
| pubmed-article:20585130 | pubmed:meshHeading | pubmed-meshheading:20585130... | lld:pubmed |
| pubmed-article:20585130 | pubmed:meshHeading | pubmed-meshheading:20585130... | lld:pubmed |
| pubmed-article:20585130 | pubmed:meshHeading | pubmed-meshheading:20585130... | lld:pubmed |
| pubmed-article:20585130 | pubmed:meshHeading | pubmed-meshheading:20585130... | lld:pubmed |
| pubmed-article:20585130 | pubmed:meshHeading | pubmed-meshheading:20585130... | lld:pubmed |
| pubmed-article:20585130 | pubmed:meshHeading | pubmed-meshheading:20585130... | lld:pubmed |
| pubmed-article:20585130 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20585130 | pubmed:articleTitle | In vitro activity of tebipenem, a new oral carbapenem antibiotic, against beta-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae. | lld:pubmed |
| pubmed-article:20585130 | pubmed:affiliation | Laboratory of Molecular Epidemiology for Infectious Agents, Kitasato Institute for Life Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan. | lld:pubmed |
| pubmed-article:20585130 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:20585130 | lld:chembl |
